Colgate-Palmolive Co (CL) concluded trading on Wednesday at a closing price of $87.66, with 4.2 million shares of worth about $367.99 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 0.64% during that period and on July 16, 2025 the price saw a loss of about -0.56%. Currently the company’s common shares owned by public are about 810.42M shares, out of which, 809.04M shares are available for trading.
Stock saw a price change of -4.28% in past 5 days and over the past one month there was a price change of -2.88%. Year-to-date (YTD), CL shares are showing a performance of -10.61% which decreased to -3.57% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $85.32 but also hit the highest price of $109.30 during that period. The average intraday trading volume for Colgate-Palmolive Co shares is 5.36 million. The stock is currently trading -2.37% below its 20-day simple moving average (SMA20), while that difference is down -3.12% for SMA50 and it goes to -4.97% lower than SMA200.
Colgate-Palmolive Co (NYSE: CL) currently have 810.42M outstanding shares and institutions hold larger chunk of about 85.55% of that.
The stock has a current market capitalization of $71.04B and its 3Y-monthly beta is at 0.36. PE ratio of stock for trailing 12 months is 24.82, while it has posted earnings per share of $3.53 in the same period. Its PEG reads 4.35 and has Quick Ratio of 0.54 while making debt-to-equity ratio of 22.78. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CL, volatility over the week remained 1.58% while standing at 1.54% over the month.
Stock’s fiscal year EPS is expected to rise by 2.02% while it is estimated to increase by 7.47% in next year. EPS is likely to grow at an annualized rate of 5.71% for next 5-years, compared to annual growth of 5.01% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Stifel on October 28, 2024 offering a Hold rating for the stock and assigned a target price range of between $105 and $101 to it. Coverage by Piper Sandler stated Colgate-Palmolive Co (CL) stock as an Overweight in their note to investors on September 24, 2024, suggesting a price target of $121 for the stock. On September 16, 2024, Wells Fargo Downgrade their recommendations, while on September 09, 2024, Deutsche Bank Downgrade their ratings for the stock with a price target of $109. Stock get a Hold rating from HSBC Securities on July 26, 2024.
